UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overview upon miR-21 in lung cancer: focus on NSCLC

Cellular and molecular life sciences : CMLS, 2018-10, Vol.75 (19), p.3539-3551

2018

Volltextzugriff (PDF)

Delphi-Experten-Konsens der Deutschen Gesellschaft für Thoraxchirurgie über die anatomische Segmentresektion bei nicht kleinzelligem Lungenkarzinom

Zentralblatt für Chirurgie, 2022-09

2022

Volltextzugriff (PDF)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S794-S795

2021

Volltextzugriff (PDF)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S795-S795

2021

Volltextzugriff (PDF)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S796-S797

2021

Volltextzugriff (PDF)

Programmed death ligand-1 expression in non-small cell lung cancer

Laboratory investigation, 2014-01, Vol.94 (1), p.107-116

2014

Volltextzugriff (PDF)

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.1438-1448

2024

Volltextzugriff (PDF)

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma

Journal of thoracic oncology, 2024-09

2024

Volltextzugriff (PDF)

Nicht kleinzelliges Lungenkarzinom – Vorreiter der personalisierten Onkologie

Deutsche medizinische Wochenschrift, 2023-09, Vol.148 (18), p.1166-1173

2023

Volltextzugriff (PDF)

Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer

Clinical lung cancer, 2024-09

2024

Volltextzugriff (PDF)

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches

Annals of oncology, 2022-09, Vol.33 (9), p.893-908

2022

Volltextzugriff (PDF)

Video-assisted mediastinoscopic lymphadenectomy (VAMLA): Mature results for staging non–small cell lung cancer with normal mediastinum

The Journal of thoracic and cardiovascular surgery, 2024-02

2024

Volltextzugriff (PDF)

Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis

Biochimica et biophysica acta. Molecular basis of disease, 2024-08, Vol.1870 (6), p.167234, Article 167234

2024

Volltextzugriff (PDF)

Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.1460-1466

2024

Volltextzugriff (PDF)

Non-small cell lung cancer: current treatment and future advances

Translational lung cancer research, 2016-06, Vol.5 (3), p.288-300

2016

Volltextzugriff (PDF)

Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer

Cancer epidemiology, 2024-12, Vol.93, p.102678, Article 102678

2024

Volltextzugriff (PDF)

Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer—A Population-based Cohort Study

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-09

2024

Volltextzugriff (PDF)

MED23 depletion induces premature senescence in NSCLC cells by interacting with BCLAF1 and then suppressing NUPR1 expression

Biochemical and biophysical research communications, 2024-10, Vol.734, p.150754, Article 150754

2024

Volltextzugriff (PDF)

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.205-215

2021

Volltextzugriff (PDF)

Super-resolution imaging reveals the role of DDR1 cluster in NSCLC proliferation

Talanta (Oxford), 2025-01, Vol.282, p.127024, Article 127024

2025

Volltextzugriff (PDF)

Chylöser Aszites bei NSCLC: Nicht alles ist maligne, was maligne aussieht

Pneumologie (Stuttgart, Germany), 2023-04, Vol.77 (12), p.1013-1015

2023

Volltextzugriff (PDF)

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

Oncoimmunology, 2017-06, Vol.6 (6), p.e1320011-e1320011

2017

Volltextzugriff (PDF)

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Oncotarget, 2018-01, Vol.9 (4), p.4637-4646

2018

Volltextzugriff (PDF)

Discovery of CLKs Inhibitors for the Treatment of Non-small Cell Lung Cancer

European journal of medicinal chemistry, 2024-12, Vol.280, p.116952, Article 116952

2024

Volltextzugriff (PDF)

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Journal of experimental & clinical cancer research, 2017-12, Vol.36 (1), Article 174

2017

Volltextzugriff (PDF)

1 – 25 von 14.591

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLung Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12.004)
Mit Volltextzugriff
(13.049)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(12.623)
Life Sciences & Biomedicine
(12.406)
Nsclc
(9.861)
Oncology
(7.499)
Humans
(6.866)
Lung Cancer
(5.170)
Lung Neoplasms - Pathology
(3.494)
Non-Small Cell Lung Cancer
(3.302)
Carcinoma, Non-Small-Cell Lung - Pathology
(3.182)
Female
(3.116)
Male
(3.057)
Lung Neoplasms - Drug Therapy
(2.881)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(2.835)
Middle Aged
(2.595)
Non-Small Cell Lung Carcinoma
(2.571)
Lung Neoplasms - Genetics
(2.499)
Carcinoma, Non-Small-Cell Lung - Genetics
(2.469)
Aged
(2.409)
Respiratory System
(2.188)
Chemotherapy
(2.049)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(9.544)
MEDLINE
(6.946)
Ingenta
(6.857)
Journals@Ovid
(3.992)
IngentaConnect Journals
(3.699)
Elsevier ScienceDirect Journals Complete
(2.283)
SpringerLink Journals - AutoHoldings
(1.964)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.430)
Wiley-Blackwell Journals
(1.265)
Taylor & Francis Journals
(1.161)
NUS Single-Journal Subscriptions
(955)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(922)
Taylor & Francis
(791)
Wiley Online Library Full Collection 2018
(583)
Taylor & Francis Online
(517)
Sage Journals
(347)
Nexis Uni
(317)
Ebook Central Perpetual and DDA
(180)
eBooks on EBSCOhost
(177)
Nature Journals
(163)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Translational Lung Cancer Research
(579)
Journal Of Thoracic Disease
(509)
Journal Of Thoracic Oncology
(481)
Frontiers In Oncology
(459)
Clinical Lung Cancer
(381)
Cancers
(373)
Oncotarget
(296)
Thoracic Cancer
(206)
Anticancer Research
(201)
Oncotargets And Therapy
(189)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Overview upon miR-21 in lung cancer: focus on NSCLC

Delphi-Experten-Konsens der Deutschen Gesellschaft für Thoraxchirurgie über die anatomische Segmentresektion bei nicht kleinzelligem Lungenkarzinom

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study

Programmed death ligand-1 expression in non-small cell lung cancer

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma

Nicht kleinzelliges Lungenkarzinom – Vorreiter der personalisierten Onkologie

Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches

Video-assisted mediastinoscopic lymphadenectomy (VAMLA): Mature results for staging non–small cell lung cancer with normal mediastinum

Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis

Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Non-small cell lung cancer: current treatment and future advances

Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer

Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer—A Population-based Cohort Study

MED23 depletion induces premature senescence in NSCLC cells by interacting with BCLAF1 and then suppressing NUPR1 expression

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Super-resolution imaging reveals the role of DDR1 cluster in NSCLC proliferation

Chylöser Aszites bei NSCLC: Nicht alles ist maligne, was maligne aussieht

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Discovery of CLKs Inhibitors for the Treatment of Non-small Cell Lung Cancer

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

Aktive Filter

Suchergebnisse filtern